Shanghai Medicilon Inc.: Investor relations activity record (2024-07-002)
Shanghai Medicilon Inc.: Investor Relations Activity Record Form (2024-07-001)
Shanghai Medicilon Inc.: Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Reply to the regulatory inquiry letter on information disclosure of the annual report of Shanghai Medicilon Inc. for the year 2023 by Ruihua Certified Public Accountants (Special General Partnership).
Shanghai Medicilon Inc.: Announcement of Reply to Information Disclosure Inquiry Letter on 2023 Annual Report Regulation.
Shanghai Medicilon Inc.: Announcement regarding the judicial freeze of a portion of the shareholder's shares.
Shanghai Medicilon Inc.: Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Shanghai Medicilon Inc.: Announcement on the initial repurchase of the company's shares through centralized bidding transactions and the progress of the repurchase
Shanghai Medicilon Inc.: Investor Relations Activity Record Form (2024-05-001)
Shanghai Medicilon Inc.: Announcement on holding the results briefing for the first quarter of 2023 and 2024
Shanghai Medicilon Inc.: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Anli (Shanghai) Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Medici Biomedical Co., Ltd.
Shanghai Medicilon Inc.: Notice on directors and senior management receiving a warning letter from the Shanghai Securities Regulatory Bureau
Shanghai Medicilon Inc.: Announcement on the implementation results of share repurchase
Shanghai Medicilon Inc.: 2023 Annual General Meeting of Shareholders Meeting Materials
Shanghai Medicilon Inc.: Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Shanghai Medicilon Inc.: Repurchase Report on the Repurchase of Shares through Centralized Auction Transactions
Shanghai Medicilon Inc.: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sale conditions in the share repurchase event
GF Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Shanghai Medici Biomedical Co., Ltd.
Shanghai Medicilon Inc.: Investor Relations Activity Record Form (2024-04-001)
No Data